These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17524317)

  • 21. Association between retinal vessel caliber and arterial stiffness in a population comprised of normotensive to early-stage hypertensive individuals.
    Triantafyllou A; Anyfanti P; Gavriilaki E; Zabulis X; Gkaliagkousi E; Petidis K; Triantafyllou G; Gkolias V; Pyrpasopoulou A; Douma S
    Am J Hypertens; 2014 Dec; 27(12):1472-8. PubMed ID: 24858306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of subjective and objective methods to determine the retinal arterio-venous ratio using fundus photography.
    Heitmar R; Kalitzeos AA; Patel SR; Prabhu-Das D; Cubbidge RP
    J Optom; 2015; 8(4):252-7. PubMed ID: 26386537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
    Devereux RB; Dahlöf B; Gerdts E; Boman K; Nieminen MS; Papademetriou V; Rokkedal J; Harris KE; Edelman JM; Wachtell K
    Circulation; 2004 Sep; 110(11):1456-62. PubMed ID: 15326072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation.
    Omboni S; Parati G; Palatini P; Vanasia A; Muiesan ML; Cuspidi C; Mancia G
    J Hypertens; 1998 Jun; 16(6):733-8. PubMed ID: 9663912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of combination therapy with losartan/hydrochlorothiazide on the relationships between base blood pressure, autonomic function, and health-related QOL].
    Okano Y; Toya Y; Azuma K; Yabana M; Tamura K; Umemura S
    Nihon Jinzo Gakkai Shi; 2010; 52(7):939-44. PubMed ID: 21077345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).
    Gerdts E; Papademetriou V; Palmieri V; Boman K; Björnstad H; Wachtell K; Giles TD; Dahlöf B; Devereux RB;
    Am J Cardiol; 2002 Feb; 89(4):399-402. PubMed ID: 11835919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood pressure variability, baroreflex sensitivity and organ damage in spontaneously hypertensive rats treated with various antihypertensive drugs.
    Xie HH; Shen FM; Zhang XF; Jiang YY; Su DF
    Eur J Pharmacol; 2006 Aug; 543(1-3):77-82. PubMed ID: 16808912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor beta in hypertensives with cardiorenal damage.
    Laviades C; Varo N; Díez J
    Hypertension; 2000 Oct; 36(4):517-22. PubMed ID: 11040229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic effects of marathon running on the retinal microcirculation.
    Pressler A; Hanssen H; Dimitrova M; Krumm M; Halle M; Scherr J
    Atherosclerosis; 2011 Dec; 219(2):864-8. PubMed ID: 21945500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of losartan potassium and its combination with hydrochlorothiazide in hypertensive disease. Focus on the state of microcirculation].
    Podzolkov VI; Son EA; Bulatov VA; Makolkin VI
    Kardiologiia; 2003; 43(11):18-22. PubMed ID: 14989241
    [No Abstract]   [Full Text] [Related]  

  • 31. Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
    Okin PM; Hille DA; Kjeldsen SE; Lindholm LH; Edelman JM; Dahlöf B; Devereux RB
    Am J Hypertens; 2010 Jul; 23(7):786-93. PubMed ID: 20395941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of antihypertensive treatment on the retinal microcirculation: an anglo-scandinavian cardiac outcomes trial substudy.
    Thom S; Stettler C; Stanton A; Witt N; Tapp R; Chaturvedi N; Allemann S; Mayet J; Sever P; Poulter N; O'Brien E; Hughes A
    Hypertension; 2009 Aug; 54(2):405-8. PubMed ID: 19528363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.
    Dahlof B; Zanchetti A; Diez J; Nicholls MG; Yu CM; Barrios V; Aurup P; Smith RD; Johansson M;
    J Hypertens; 2002 Sep; 20(9):1855-64. PubMed ID: 12195129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [New goals in hypertension management: target-organ protection beyond blood pressure lowering].
    Safar ME; Struijker-Boudier HA
    Drugs; 2003; 63 Spec No 1():45-7. PubMed ID: 12708882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic science: hypertensive target organ damage.
    Bidani AK; Griffin KA
    J Am Soc Hypertens; 2015 Mar; 9(3):235-7; quiz 238. PubMed ID: 25670252
    [No Abstract]   [Full Text] [Related]  

  • 36. Fixed-dose manidipine/delapril versus losartan/hydrochlorothiazide in hypertensive patients with type 2 diabetes and microalbuminuria.
    Kohlmann O; Roca-Cusachs A; Laurent S; Schmieder RE; Wenzel RR; Fogari R
    Adv Ther; 2009 Mar; 26(3):313-24. PubMed ID: 19330493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cooperation with ophthalmologists becomes ever more important -- eyes under pressure].
    Aumiller J
    MMW Fortschr Med; 2005 Jan; 147(1-2):41, 43-4. PubMed ID: 15704570
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of an automated system to classify retinal vessels into arteries and veins.
    Saez M; González-Vázquez S; González-Penedo M; Barceló MA; Pena-Seijo M; Coll de Tuero G; Pose-Reino A
    Comput Methods Programs Biomed; 2012 Oct; 108(1):367-76. PubMed ID: 22424729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining hypertensive end-organ damage in trials: a review of current methodologies and techniques.
    Birkenhäger WH; de Leeuw PW
    J Cardiovasc Pharmacol; 1992; 19 Suppl 5():S43-50. PubMed ID: 1381794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.
    Cuspidi C; Meani S; Valerio C; Fusi V; Catini E; Sala C; Magrini F; Zanchetti A
    Blood Press; 2005; 14(1):25-31. PubMed ID: 15823944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.